Depression among patients with multi-drug resistant tuberculosis (MDR-TB) in Bangladesh

The data set is derived from a cross-sectional survey among 150 multi-drug resistant tuberculosis (MDR-TB) in-patients in the National Institute of Diseases of the Chest and Hospital (NIDCH) in Dhaka, Bangladesh. The aims of the study were to statistically validate the PHQ-9 depression screening tool among MDR-TB in-patients within this context, measure the prevalence of depression among MDR-TB in-patients within this context, and explore the associations between socio-demographic and health related variables and depression status among MDR-TB in-patients within this context. The data were collected in 2018 from all consenting in-patients between January and July 2018. The data includes socio-demographic variables, self-report details of co-morbidities and responses to the PHQ9 question-set for depression. The PHQ-9 assessments were repeated after two weeks to assess the tool’s consistency over time. Also as part of the validation of PHQ-9, within a two-week period a psychiatrist assessed depression among patients using the Structured Clinical Interview for Depression (SCID DSM-IV). These results are also included in the data set to serve as a “gold standard” for the PHQ-9 validation. Two patients left (without being discharged) the hospital before the SCID interview could be conducted, so the SCID data is only available for 148 of the 150 respondents.